Publications
Sort:
Open Access Research Article Issue
Infectious Diseases and the Use of Antimicrobials on Space Missions
Space: Science & Technology 2024, 4: 0205
Published: 27 December 2024
Abstract PDF (707.8 KB) Collect
Downloads:0
Introduction

Exposure of the human body to the aerospace environment is capable of producing various physiological changes, which contributes to greater susceptibility of acquiring viral and/or bacterial infections.

Objective

To review studies on the use of antimicrobials in space to provide up-to-date information on the treatment of infectious diseases and contribute to the safety and well-being of astronauts on space voyages.

Method

Integrative literature review, using DeCS (https://decs.bvsalud.org/) and PubMed (https://pubmed.ncbi.nlm.nih.gov/).

Results and Discussion

Prolonged exposure to microgravity, radiation, and confinement can potentially affect the dynamics of interactions between microorganisms and Homo sapiens, causing astronauts to be more susceptible to infections in the aerospace environment. This context becomes more complex when we consider the greater possibility of drug-resistant bacterial strains emerging—due to radiation-related mutations—and the conditions that affect antimicrobial stability, especially excessive vibrations, a carbon dioxide-rich atmosphere, and variations in humidity temperature fluctuations. Additionally, physiological changes experienced by humans in the extraterrestrial environment—e.g., cardiovascular, respiratory, and renal—can alter the pharmacokinetics of antimicrobials.

Conclusion

Understanding the context in which astronauts are inserted, the risks involved, and how to avoid theses is essential for ensuring the safety and continuity of space missions with regards to diseases and the use of antimicrobials, which will allow humanity in space to have a “long and prosperous life”.

Total 1